RE: Science Day25 Nov 2022 08:55
Sounds like it's for everyone:
The Company looks forward to providing a full technical update to shareholders on the Affimer immunotherapy and pre|CISION chemotherapy programmes as part of a Science Day event when the data sets from the preclinical and clinical programmes are in hand, so that the data can be presented and the development path and associated risks for the programmes can be described in detail.